Vascular Biology

In vivo comparison of a polymer-free Biolimus A9-eluting stent with a biodegradable polymer-based Biolimus A9 eluting stent and a bare metal stent in balloon denuded and radiated hypercholesterolemic rabbit iliac arteries†

  1. Ron Waksman MD1,*,
  2. Rajbabu Pakala PhD1,†,
  3. Richard Baffour PhD1,†,
  4. Rufus Seabron1,†,
  5. David Hellinga MSc1,†,
  6. Rosanna Chan PhD1,†,
  7. Shih-Horng Su PhD2,†,
  8. Frank Kolodgie PhD3,†,
  9. Renu Virmani MD3,†

Article first published online: 1 DEC 2011

DOI: 10.1002/ccd.23407

Issue

Catheterization and Cardiovascular Interventions

Catheterization and Cardiovascular Interventions

Volume 80, Issue 3, pages 429–436, 1 September 2012

Additional Information

How to Cite

Waksman, R., Pakala, R., Baffour, R., Seabron, R., Hellinga, D., Chan, R., Su, S.-H., Kolodgie, F. and Virmani, R. (2012), In vivo comparison of a polymer-free Biolimus A9-eluting stent with a biodegradable polymer-based Biolimus A9 eluting stent and a bare metal stent in balloon denuded and radiated hypercholesterolemic rabbit iliac arteries. Cathet. Cardiovasc. Intervent., 80: 429–436. doi: 10.1002/ccd.23407

Author Information

  1. 1

    Cardiovascular Research Institute, Washington Hospital Center, Washington, D.C.

  2. 2

    Biosensors International, Singapore

  3. 3

    CV Path, Gaithersburg, Maryland

  1. †

    Conflict of interest: Ron Waksman has received consulting and speaker fees from Biotronik, Medtronic, and Boston Scientific. Has received research grants from Biotronik, Boston Scientific, the Medicines Co., GlaxoSmithKline, Schering-Plough, and Sanofi-Aventis. Rajbabu Pakala: None. Richard Baffour: None. Rufus Seabron: None. David Hellinga: None. Rosanna Chan: None. Shih-Horng Su: Employee Biosensors International, Singapore. Frank Kolodgie: None. Renu Virmani: Received research support from 3F Therapeutics, Abbott Vascular, Amaranth Medical, Inc., Apnex Medical, Ardian, Inc., Atrium Medical Corporation, CardioDex, Ltd., CardioKinetix, Inc., CorAssist Cardiovascular, Ltd., Cordis Corporation, Devax, Inc., ev3, Gardia Medical, Ltd., GlaxoSmithKline, HemCon, Lutonix, Inc., Medtronic Vascular, Meril Life Sciences Pvt, Ltd., Microvention, Inc., Novartis Pharmaceuticals Corporation, NovoStent Corporation, Oregon Medical Laser Center, Prescient Medical, Inc., Relisys Medical Devices Limited, Vascular Therapies, LLC, and Xtent, Inc.; and is a consultant to Medtronic AVE, Abbott Vascular, W. L. Gore, Volcano Therapeutics, Inc., Prescient Medical Inc., CardioMind, Inc., Direct Flow, and Atrium Medical Corporation.

*Washington Hospital Center, 110 Irving Street, NW, Suite 4B-1, Washington, DC 20010

  1. †

    Conflict of interest: Ron Waksman has received consulting and speaker fees from Biotronik, Medtronic, and Boston Scientific. Has received research grants from Biotronik, Boston Scientific, the Medicines Co., GlaxoSmithKline, Schering-Plough, and Sanofi-Aventis. Rajbabu Pakala: None. Richard Baffour: None. Rufus Seabron: None. David Hellinga: None. Rosanna Chan: None. Shih-Horng Su: Employee Biosensors International, Singapore. Frank Kolodgie: None. Renu Virmani: Received research support from 3F Therapeutics, Abbott Vascular, Amaranth Medical, Inc., Apnex Medical, Ardian, Inc., Atrium Medical Corporation, CardioDex, Ltd., CardioKinetix, Inc., CorAssist Cardiovascular, Ltd., Cordis Corporation, Devax, Inc., ev3, Gardia Medical, Ltd., GlaxoSmithKline, HemCon, Lutonix, Inc., Medtronic Vascular, Meril Life Sciences Pvt, Ltd., Microvention, Inc., Novartis Pharmaceuticals Corporation, NovoStent Corporation, Oregon Medical Laser Center, Prescient Medical, Inc., Relisys Medical Devices Limited, Vascular Therapies, LLC, and Xtent, Inc.; and is a consultant to Medtronic AVE, Abbott Vascular, W. L. Gore, Volcano Therapeutics, Inc., Prescient Medical Inc., CardioMind, Inc., Direct Flow, and Atrium Medical Corporation.

Publication History

  1. Issue published online: 29 AUG 2012
  2. Article first published online: 1 DEC 2011
  3. Accepted manuscript online: 22 NOV 2011 01:14AM EST
  4. Manuscript Accepted: 2 OCT 2011
  5. Manuscript Revised: 5 AUG 2011
  6. Manuscript Received: 11 MAR 2011

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

Get PDF (307K)

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • If you would like institutional access to this content, please recommend the title to your librarian.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

If your institution is a registered Wiley Online Library customer, you can log in under your institution's name to see our content. This access is provided by Shibboleth or Athens.

Type your institution's name in the box below. If your institution is a Wiley customer, it will appear in the list of suggested institutions.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Get PDF (307K)